{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T01:50:34Z","timestamp":1769737834660,"version":"3.49.0"},"update-to":[{"DOI":"10.1371\/journal.pgen.1007355","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000}}],"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T00:00:00Z","timestamp":1523836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (PT)","award":["PEst-OE\/SAU\/UI0776\/2014"],"award-info":[{"award-number":["PEst-OE\/SAU\/UI0776\/2014"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (PT)","award":["PTDC\/DTP-PIC\/1308\/2014"],"award-info":[{"award-number":["PTDC\/DTP-PIC\/1308\/2014"]}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/DTP\/00776\/2013\/POCI-01-0145-FEDER-006868"],"award-info":[{"award-number":["UID\/DTP\/00776\/2013\/POCI-01-0145-FEDER-006868"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/71397\/2010"],"award-info":[{"award-number":["SFRH\/BD\/71397\/2010"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/73719\/2010"],"award-info":[{"award-number":["SFRH\/BD\/73719\/2010"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Portuguese Oncology Institute of Porto - Research Center (PT)","award":["CI-IPOP-16-2012"],"award-info":[{"award-number":["CI-IPOP-16-2012"]}]},{"name":"Liga Portuguesa Contra o Cancro - N\u00facleo Regional do Norte (PT)"}],"content-domain":{"domain":["www.plosgenetics.org"],"crossmark-restriction":false},"short-container-title":["PLoS Genet"],"DOI":"10.1371\/journal.pgen.1007355","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T13:34:27Z","timestamp":1523885667000},"page":"e1007355","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgen.corrections_policy","source":"Crossref","is-referenced-by-count":57,"title":["Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset\/familial prostate cancer"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8387-2127","authenticated-orcid":true,"given":"Paula","family":"Paulo","sequence":"first","affiliation":[]},{"given":"Sofia","family":"Maia","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Augusta","family":"Monteiro","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Peixoto","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3633-1659","authenticated-orcid":true,"given":"Manuel R.","family":"Teixeira","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2018,4,16]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer Statistics, 2015","volume":"65","author":"RL Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","article-title":"EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013","volume":"65","author":"A Heidenreich","year":"2014","journal-title":"Eur Urol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/oxfordjournals.epirev.a000789","article-title":"Familial prostate cancer","volume":"23","author":"JL Stanford","year":"2001","journal-title":"Epidemiol Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2741\/1891","article-title":"Prostate cancer epidemiology","volume":"11","author":"AW Hsing","year":"2006","journal-title":"Front Biosci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1073\/pnas.89.8.3367","article-title":"Mendelian inheritance of familial prostate cancer","volume":"89","author":"BS Carter","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1634\/theoncologist.2009-0132","article-title":"Age at diagnosis and age at death in familial prostate cancer","volume":"14","author":"A Brandt","year":"2009","journal-title":"Oncologist"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/(SICI)1097-0045(19971201)33:4<240::AID-PROS3>3.0.CO;2-L","article-title":"Heredity and prostate cancer: a study of World War II veteran twins","volume":"33","author":"WF Page","year":"1997","journal-title":"Prostate"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"P Lichtenstein","year":"2000","journal-title":"N Engl J Med"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nrurol.2012.185","article-title":"The complexity of prostate cancer: genomic alterations and heterogeneity","volume":"9","author":"LK Boyd","year":"2012","journal-title":"Nat Rev Urol"},{"issue":"16","key":"ref10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/djh228","article-title":"Combined genome-wide scan for prostate cancer susceptibility genes","volume":"96","author":"EM Gillanders","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"8899","key":"ref11","first-page":"692","article-title":"Risks of cancer in BRCA1-mutation carriers","volume":"343","author":"D Ford","year":"1994","journal-title":"Breast Cancer Linkage Consortium. Lancet"},{"issue":"20","key":"ref12","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"JP Struewing","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJMoa1110000","article-title":"Germline mutations in HOXB13 and prostate-cancer risk","volume":"366","author":"CM Ewing","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00439-012-1229-4","article-title":"HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)","volume":"132","author":"J Xu","year":"2013","journal-title":"Hum Genet"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s13277-013-1157-5","article-title":"G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis","volume":"35","author":"H Huang","year":"2014","journal-title":"Tumour Biol"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/pros.22552","article-title":"A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men","volume":"73","author":"X Lin","year":"2013","journal-title":"Prostate"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"e0132728","DOI":"10.1371\/journal.pone.0132728","article-title":"Identification of two novel HOXB13 germline mutations in Portuguese prostate cancer patients","volume":"10","author":"S Maia","year":"2015","journal-title":"PLoS One"},{"issue":"15","key":"ref18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/345310","article-title":"Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene","volume":"72","author":"SM Edwards","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/bjc.2011.383","article-title":"BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients","volume":"105","author":"Z Kote-Jarai","year":"2011","journal-title":"Br J Cancer"},{"issue":"16","key":"ref21","first-page":"3663","article-title":"High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients","volume":"56","author":"G Johannesdottir","year":"1996","journal-title":"Cancer Res"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1158\/1078-0432.CCR-03-0604","article-title":"BRCA mutations and risk of prostate cancer in Ashkenazi Jews","volume":"10","author":"T Kirchhoff","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"26","key":"ref23","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1200\/JCO.2005.03.7333","article-title":"Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium","volume":"24","author":"T Goecke","year":"2006","journal-title":"J Clin Oncol"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1158\/1055-9965.EPI-09-0058","article-title":"Germline mutations in mismatch repair genes associated with prostate cancer","volume":"18","author":"EM Grindedal","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/gim.2013.193","article-title":"Prostate cancer incidence in males with Lynch syndrome","volume":"16","author":"S Haraldsdottir","year":"2014","journal-title":"Genet Med"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10689-014-9744-1","article-title":"High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry","volume":"13","author":"C Rosty","year":"2014","journal-title":"Fam Cancer"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10689-015-9832-x","article-title":"The role of germline mutations in the BRCA1\/2 and mismatch repair genes in men ascertained for early-onset and\/or familial prostate cancer","volume":"15","author":"S Maia","year":"2016","journal-title":"Fam Cancer"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/sj.bjc.6601425","article-title":"CHEK2 variants associate with hereditary prostate cancer","volume":"89","author":"EH Sepp\u00e4l\u00e4","year":"2003","journal-title":"Br J Cancer"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1086\/346094","article-title":"Mutations in CHEK2 associated with prostate cancer risk","volume":"72","author":"X Dong","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1158\/0008-5472.CAN-04-0341","article-title":"A novel founder CHEK2 mutation is associated with increased prostate cancer risk","volume":"64","author":"C Cybulski","year":"2004","journal-title":"Cancer Res"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jmg.2006.044974","article-title":"A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer","volume":"43","author":"C Cybulski","year":"2006","journal-title":"J Med Genet"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1158\/0008-5472.CAN-03-2502","article-title":"NBS1 is a prostate cancer susceptibility gene","volume":"64","author":"C Cybulski","year":"2004","journal-title":"Cancer Res"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/138920208784533610","article-title":"NBS1 Heterozygosity and cancer risk","volume":"9","author":"A di Masi","year":"2008","journal-title":"Curr Genomics"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.bjc.6602007","article-title":"ATM polymorphisms as risk factors for prostate cancer development","volume":"17","author":"S Ang\u00e8le","year":"2004","journal-title":"Br J Cancer"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/bjc.2014.30","article-title":"Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease","volume":"110","author":"D Leongamornlert","year":"2014","journal-title":"Br J Cancer"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/sj.bjc.6604847","article-title":"A recurrent truncating germline mutation in the BRIP1\/FANCJ gene and susceptibility to prostate cancer","volume":"100","author":"Z Kote-Jarai","year":"2009","journal-title":"Br J Cancer"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jmoldx.2017.05.001","article-title":"Validation of a next generation sequencing pipeline for the molecular diagnosis of multiple inherited cancer predisposing syndromes","volume":"19","author":"P Paulo","year":"2017","journal-title":"J Mol Diagnostics"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10549-016-3948-z","article-title":"Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity","volume":"159","author":"P Pinto","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-biophys-051013-022737","article-title":"The Fanconi anemia DNA repair pathway: structural and functional insights into a complex disorder","volume":"43","author":"H Walden","year":"2014","journal-title":"Annu Rev Biophys"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40246-015-0054-y","article-title":"Update of the human and mouse Fanconi anemia genes","volume":"9","author":"H Dong","year":"2015","journal-title":"Hum Genomics"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/bcr2099","article-title":"Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?","volume":"10","author":"GB Byrnes","year":"2008","journal-title":"Breast Cancer Res"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/cge.12548","article-title":"Genetic testing for RAD51C mutations: in the clinic and community","volume":"88","author":"V Sopik","year":"2014","journal-title":"Clin Genet"},{"key":"ref43","first-page":"1","article-title":"PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS","author":"MC Southey","year":"2016","journal-title":"J Med Genet"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ng.569","article-title":"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene","volume":"42","author":"A Meindl","year":"2010","journal-title":"Nat Genet"},{"issue":"15","key":"ref45","doi-asserted-by":"crossref","first-page":"E1898","DOI":"10.1073\/pnas.1422238112","article-title":"\u03b1IIb\u03b23 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia","volume":"112","author":"L Buitrago","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"15","author":"S Richards","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","article-title":"InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines","volume":"100","author":"Q Li","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"18","key":"ref48","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1158\/0008-5472.CAN-06-1990","article-title":"Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activation","volume":"66","author":"N Sodha","year":"2006","journal-title":"Cancer Res"},{"issue":"12","key":"ref49","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/hmg\/dds101","article-title":"Response to DNA damage of CHEK2 missense mutations in familial breast cancer","volume":"21","author":"W Roeb","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/sj.bjc.6605822","article-title":"Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis","volume":"103","author":"SM Edwards","year":"2010","journal-title":"Br J Cancer"},{"issue":"8","key":"ref51","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.semcdb.2011.07.019","article-title":"RAD51 paralogs: Roles in DNA damage signalling, recombinational repair and tumorigenesis","volume":"22","author":"N Suwaki","year":"2011","journal-title":"Semin Cell Dev Biol"},{"issue":"7","key":"ref52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrc3088","article-title":"DNA interstrand crosslink repair and cancer","volume":"11","author":"AJ Deans","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ajmg.10281","article-title":"High risk of malignancy in mosaic variegated aneuploidy syndrome","volume":"109","author":"S Jacquemont","year":"2002","journal-title":"Am J Med Genet"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ng.822","article-title":"Mutations in CEP57 cause mosaic variegated aneuploidy syndrome","volume":"43","author":"K Snape","year":"2011","journal-title":"Nat Genet"},{"issue":"2","key":"ref55","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mrrev.2012.12.004","article-title":"Disease-causing missense mutations in human DNA helicase disorders","volume":"752","author":"AN Suhasini","year":"2013","journal-title":"Mutat Res"},{"issue":"12","key":"ref56","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1002\/ijc.26342","article-title":"High prevalence and breast cancer predisposing role of the BLM c.1642 C&gt;T (Q548X) mutation in Russia","volume":"130","author":"AP Sokolenko","year":"2012","journal-title":"Int J Cancer"},{"issue":"6","key":"ref57","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ng.3284","article-title":"Germline RECQL mutations are associated with breast cancer susceptibility","volume":"47","author":"C Cybulski","year":"2015","journal-title":"Nat Genet"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10549-014-3187-0","article-title":"The frequency of the BLM p.Q548X (c.1642C&gt;T) mutation in breast cancer patients from Russia is no higher than in the general population","volume":"148","author":"MS Anisimenko","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"ref59","doi-asserted-by":"crossref","first-page":"e1002894","DOI":"10.1371\/journal.pgen.1002894","article-title":"Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles","volume":"8","author":"ER Thompson","year":"2012","journal-title":"PLoS Genet"},{"issue":"17","key":"ref60","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1016\/j.yexcr.2006.07.023","article-title":"The Rothmund-Thomson gene product RECQL4 localizes to the nucleolus in response to oxidative stress","volume":"312","author":"L Woo","year":"2006","journal-title":"Exp Cell Res"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10549-007-9543-6","article-title":"The spectrum of ATM missense variants and their contribution to contralateral breast cancer","volume":"107","author":"A Broeks","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"ref62","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2217\/bmm.13.143","article-title":"Growing recognition of the role for rare missense substitutions in breast cancer susceptibility","volume":"8","author":"S V Tavtigian","year":"2014","journal-title":"Biomark Med"},{"issue":"4","key":"ref63","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/373965","article-title":"Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility","volume":"72","author":"M Schutte","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"7","key":"ref64","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/gim.2013.73","article-title":"ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing","volume":"15","author":"RC Green","year":"2013","journal-title":"Genet Med"},{"issue":"10","key":"ref65","doi-asserted-by":"crossref","first-page":"e1003876","DOI":"10.1371\/journal.pgen.1003876","article-title":"Eleven candidate susceptibility genes for common familial colorectal cancer","volume":"9","author":"AE Gylfe","year":"2013","journal-title":"PLoS Genet"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/gim.2014.89","article-title":"Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer","volume":"17","author":"C Esteban-Jurado","year":"2014","journal-title":"Genet Med"},{"issue":"7319","key":"ref67","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing","volume":"467","author":"GR Abecasis","year":"2010","journal-title":"Nature"},{"issue":"5","key":"ref68","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/humu.21438","article-title":"LOVD v.2.0: the next generation in gene variant databases","volume":"32","author":"Taschner PEM Fokkema IFAC","year":"2011","journal-title":"Hum Mutat"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2105-13-134","article-title":"Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction","volume":"13","author":"J Ye","year":"2012","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"ref70","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ijc.20269","article-title":"Mutation analysis of the RECQL4 gene in sporadic osteosarcomas","volume":"111","author":"K Nishijo","year":"2004","journal-title":"Int J Cancer"},{"issue":"4","key":"ref71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"JM Schwarz","year":"2014","journal-title":"Nat Methods"},{"issue":"D1","key":"ref72","first-page":"D204","article-title":"UniProt: a hub for protein information","volume":"43","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"ref73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkp215","article-title":"Human Splicing Finder: An online bioinformatics tool to predict splicing signals","volume":"37","author":"FO Desmet","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/1066527041410418","article-title":"Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals","volume":"11","author":"G Yeo","year":"2004","journal-title":"J Comput Biol"},{"issue":"3","key":"ref75","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cmb.1997.4.311","article-title":"Improved splice site detection in Genie","volume":"4","author":"MG Reese","year":"1997","journal-title":"J Comput Biol"},{"issue":"17","key":"ref76","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/nar\/24.17.3439","article-title":"Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information","volume":"24","author":"SM Hebsgaard","year":"1996","journal-title":"Nucleic Acids Res"}],"updated-by":[{"DOI":"10.1371\/journal.pgen.1007355","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000}}],"container-title":["PLOS Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pgen.1007355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T08:53:51Z","timestamp":1540198431000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgen.1007355"}},"subtitle":[],"editor":[{"given":"Charis","family":"Eng","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2018,4,16]]},"references-count":76,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgen.1007355","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pgen.1007355","asserted-by":"object"}]},"ISSN":["1553-7404"],"issn-type":[{"value":"1553-7404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,16]]}}}